PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17658665-1	2007	Mice lacking the PACAP gene (PACAP(-/-)) display psychomotor abnormalities such as novelty-induced hyperactivity and jumping behavior, and they show different responses to amphetamine, a typical psychostimulant.	Amphetamine	172-183	adenylate cyclase activating polypeptide 1	Mus musculus	17-22	
19270432-2	2009	Our previous study also showed that hyperactivity in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP) was ameliorated by amphetamine in a serotonin (5-HT)(1A)-dependent manner and that amphetamine calmed wild-type mice given the 5-HT(1A) agonist 8-OH-DPAT.	Amphetamine	144-155	adenylate cyclase activating polypeptide 1	Mus musculus	66-124	
16687500-3	2006	In this study, Adcyap1(-/-) mice showed sensory-motor gating deficits, measured as deficits in prepulse inhibition (PPI), and showed normal PPI in response to amphetamine.	Amphetamine	159-170	adenylate cyclase activating polypeptide 1	Mus musculus	15-22	
16687500-4	2006	Amphetamine also significantly decreased hyperlocomotion in Adcyap1(-/-) mice, and this paradoxical antihyperkinetic effect depended on serotonin 1A (5-HT(1A)) receptor signaling.	Amphetamine	0-11	adenylate cyclase activating polypeptide 1	Mus musculus	60-67	
16687500-5	2006	c-Fos-positive neurons were increased in the prefrontal cortex in amphetamine-treated Adcyap1(-/-) mice, suggesting increased inhibitory control by prefrontal neurons.	Amphetamine	66-77	adenylate cyclase activating polypeptide 1	Mus musculus	86-93